Payment overview · 2025
General Payments
We did not find matching Open Payments records for this doctor in the selected program year.
Healthcare provider profile · identity verified
Internal Medicine · CLEARWATER, FL · NPI 1669470746
Verified facts
We did not find matching Open Payments records for this doctor in 2025.
These records do not establish that a payment influenced prescribing or medical care.
Payment overview · 2025
We did not find matching Open Payments records for this doctor in the selected program year.
Separate record types
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Analysis 1 · Payment-linked products
No payment-linked product analysis is available because no matching General Payment records were found for the selected year.
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
There is no payer-company set available for this comparison.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 726 | 230 |
| Amlodipine Besylate | Amlodipine Besylate | 620 | 184 |
| Losartan Potassium | Losartan Potassium | 370 | 117 |
| Levothyroxine Sodium | Levothyroxine Sodium | 361 | 107 |
| Lisinopril | Lisinopril | 326 | 99 |
| Metformin Hcl | Metformin Hcl | 297 | 99 |
| Alprazolam | Alprazolam | 290 | 56 |
| Gabapentin | Gabapentin | 278 | 88 |
| Tramadol Hcl | Tramadol Hcl | 270 | 64 |
| Trazodone Hcl | Trazodone Hcl | 221 | 57 |
| Omeprazole | Omeprazole | 188 | 62 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 176 | 70 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 174 | 56 |
| Metoprolol Succinate | Metoprolol Succinate | 148 | 49 |
| Simvastatin | Simvastatin | 144 | 47 |
| Escitalopram Oxalate | Escitalopram Oxalate | 136 | 39 |
| Pantoprazole Sodium | Pantoprazole Sodium | 131 | 44 |
| Tamsulosin Hcl | Tamsulosin Hcl | 130 | 44 |
| Hydrochlorothiazide | Hydrochlorothiazide | 128 | 44 |
| Furosemide | Furosemide | 126 | 43 |
| Metoprolol Tartrate | Metoprolol Tartrate | 119 | 45 |
| Clopidogrel | Clopidogrel Bisulfate | 111 | 36 |
| Methylprednisolone | Methylprednisolone | 109 | 78 |
| Lorazepam | Lorazepam | 99 | 23 |
| Tizanidine Hcl | Tizanidine Hcl | 98 | 33 |
| Sertraline Hcl | Sertraline Hcl | 97 | 31 |
| Carvedilol | Carvedilol | 91 | 31 |
| Eliquis | Apixaban | 87 | 23 |
| Azithromycin | Azithromycin | 84 | 66 |
| Cefdinir | Cefdinir | 83 | 61 |
| Fluticasone Propionate | Fluticasone Propionate | 68 | 22 |
| Allopurinol | Allopurinol | 66 | 23 |
| Ezetimibe | Ezetimibe | 65 | 20 |
| Clonazepam | Clonazepam | 64 | 14 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 64 | 17 |
| Ibuprofen | Ibuprofen | 59 | 15 |
| Finasteride | Finasteride | 58 | 16 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 56 | 17 |
| Potassium Chloride | Potassium Chloride | 56 | 18 |
| Glipizide Er | Glipizide | 55 | 17 |
| Spironolactone | Spironolactone | 55 | 15 |
| Ropinirole Hcl | Ropinirole Hcl | 54 | 11 |
| Alendronate Sodium | Alendronate Sodium | 53 | 20 |
| Duloxetine Hcl | Duloxetine Hcl | 53 | 17 |
| Montelukast Sodium | Montelukast Sodium | 53 | 20 |
| Atenolol | Atenolol | 50 | 17 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 50 | 35 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 49 | 16 |
| Oxybutynin Chloride | Oxybutynin Chloride | 49 | 20 |
| Citalopram Hbr | Citalopram Hydrobromide | 48 | 14 |
| Baclofen | Baclofen | 47 | 14 |
| Meloxicam | Meloxicam | 45 | 20 |
| Terazosin Hcl | Terazosin Hcl | 43 | 14 |
| Warfarin Sodium | Warfarin Sodium | 42 | suppressed |
| Prednisone | Prednisone | 38 | 15 |
| Zolpidem Tartrate | Zolpidem Tartrate | 36 | 14 |
| Pravastatin Sodium | Pravastatin Sodium | 35 | 13 |
| Sumatriptan Succinate | Sumatriptan Succinate | 35 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 35 | 23 |
| Pioglitazone Hcl | Pioglitazone Hcl | 34 | suppressed |
| Famotidine | Famotidine | 33 | 12 |
| Hydralazine Hcl | Hydralazine Hcl | 33 | suppressed |
| Amoxicillin | Amoxicillin | 32 | 17 |
| Glipizide | Glipizide | 32 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 32 | suppressed |
| Diazepam | Diazepam | 30 | 12 |
| Ondansetron Hcl | Ondansetron Hcl | 30 | 11 |
| Synthroid | Levothyroxine Sodium | 30 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 28 | 14 |
| Jardiance | Empagliflozin | 28 | suppressed |
| Xarelto | Rivaroxaban | 28 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 27 | suppressed |
| Ramipril | Ramipril | 27 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 26 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 25 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 25 | 11 |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 24 | suppressed |
| Irbesartan | Irbesartan | 24 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 24 | suppressed |
| Primidone | Primidone | 24 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 23 | suppressed |
| Estradiol | Estradiol | 23 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 23 | suppressed |
| Topiramate | Topiramate | 23 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 23 | suppressed |
| Calcitriol | Calcitriol | 22 | suppressed |
| Celecoxib | Celecoxib | 22 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 22 | 21 |
| Levemir Flexpen | Insulin Detemir | 22 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 22 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 22 | suppressed |
| Benzonatate | Benzonatate | 21 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 21 | suppressed |
| Ondansetron Odt | Ondansetron | 21 | suppressed |
| Pregabalin | Pregabalin | 21 | suppressed |
| Bupropion Xl | Bupropion Hcl | 20 | suppressed |
| Cephalexin | Cephalexin | 20 | 17 |
| Fluoxetine Hcl | Fluoxetine Hcl | 20 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 20 | suppressed |
| Tadalafil | Tadalafil | 20 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 19 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 19 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 19 | suppressed |
| Glimepiride | Glimepiride | 19 | suppressed |
| Ozempic | Semaglutide | 19 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 19 | 11 |
| Cyclosporine | Cyclosporine | 18 | suppressed |
| Fenofibrate | Fenofibrate | 18 | suppressed |
| Breyna | Budesonide/Formoterol Fumarate | 17 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 17 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 17 | suppressed |
| Lansoprazole | Lansoprazole | 17 | suppressed |
| Levetiracetam | Levetiracetam | 17 | suppressed |
| Stiolto Respimat | Tiotropium Br/Olodaterol Hcl | 17 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 16 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 16 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 16 | suppressed |
| Temazepam | Temazepam | 16 | suppressed |
| Valsartan | Valsartan | 16 | suppressed |
| Acyclovir | Acyclovir | 15 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 15 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 15 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 15 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 14 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 14 | suppressed |
| Diclofenac Sodium Er | Diclofenac Sodium | 13 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 13 | suppressed |
| Nifedipine Er | Nifedipine | 13 | suppressed |
| Saxagliptin Hcl | Saxagliptin Hcl | 13 | suppressed |
| Semglee (Yfgn) Pen | Insulin Glargine-Yfgn | 13 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 13 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 12 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 12 | suppressed |
| Ketoconazole | Ketoconazole | 12 | suppressed |
| Lovastatin | Lovastatin | 12 | suppressed |
| Nystatin | Nystatin | 12 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 12 | suppressed |
| Chlorthalidone | Chlorthalidone | 11 | suppressed |
| Levofloxacin | Levofloxacin | 11 | suppressed |
| Repaglinide | Repaglinide | 11 | suppressed |
Timeline
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | — | — | — | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error